SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001078782-20-000029
Filing Date
2020-01-17
Accepted
2020-01-17 17:18:15
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A 13g010820_sc13gz.htm SC 13G/A 39023
  Complete submission text file 0001078782-20-000029.txt   40734
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Subject) CIK: 0001570562 (see all company filings)

IRS No.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90861 | Film No.: 20534391
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4040 MACARTHUR BOULEVARD SUITE 310 NEWPORT BEACH CA 92660
Business Address 4040 MACARTHUR BOULEVARD SUITE 310 NEWPORT BEACH CA 92660 949-284-4555
AEON Biopharma, Inc. (Filed by) CIK: 0001622667 (see all company filings)

IRS No.: 454777018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 2834 Pharmaceutical Preparations